Provided by Tiger Fintech (Singapore) Pte. Ltd.

Regenxbio

9.61
+1.2514.95%
Post-market: 9.800.1900+1.98%17:20 EDT
Volume:1.91M
Turnover:17.92M
Market Cap:482.04M
PE:-3.10
High:9.78
Open:8.42
Low:8.32
Close:8.36
Loading ...

Press Release: REGENXBIO Announces Strategic Royalty Monetization Agreement for Up to $250 Million

Dow Jones
·
20 May

Director Kenneth T. Mills Reports Disposal of Common Shares in Regenxbio Inc

Reuters
·
15 May

BRIEF-FDA Accepts Biologics License Application For Mucopolysaccharidosis II Treatment

Reuters
·
14 May

FDA Accepts Biologics License Application for Mucopolysaccharidosis Ii Treatment

THOMSON REUTERS
·
14 May

Regenxbio Inc - FDA Grants Priority Review With Pdufa Date November 9, 2025

THOMSON REUTERS
·
14 May

Nippon Shinyaku Announces Strategic Partnership to Launch Investigational Gene Therapy RGX-121 for MPS II in U.S. and Asia

Reuters
·
14 May

Regenxbio Says Potential Hunter Syndrome Treatment Granted FDA Priority Review

MT Newswires Live
·
13 May

BRIEF-Regenxbio Announces FDA Acceptance And Priority Review Of BLA For Rgx-121 For Mps Ii

Reuters
·
13 May

Regenxbio Inc. Announces FDA Acceptance and Priority Review of RGX-121 for MPS II; PDUFA Target Action Date Set for November 9, 2025

Reuters
·
13 May

Regenxbio Announces FDA Acceptance and Priority Review of the Bla for Rgx-121 for Mps Ii

THOMSON REUTERS
·
13 May

Regenxbio Inc - FDA Grants Priority Review for Rgx-121, Action Date Nov 9, 2025

THOMSON REUTERS
·
13 May

Bank of America Securities Sticks to Its Buy Rating for RegenXBio (RGNX)

TIPRANKS
·
13 May

Regenxbio Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
13 May

BRIEF-Regenxbio Q1 Net Income USD 6.083 Million

Reuters
·
13 May

Regenxbio Q1 EPS $0.12 Misses $0.22 Estimate, Sales $89.01M Miss $101.97M Estimate

Benzinga
·
13 May

Regenxbio Inc: Expects Balance of $272.7 Mln as of March 31, 2025 to Fund Its Operations Into H2 2026

THOMSON REUTERS
·
13 May

Regenxbio Inc expected to post earnings of 48 cents a share - Earnings Preview

Reuters
·
10 May

Regenxbio (RGNX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Zacks
·
05 May

REGENXBIO to Host Conference Call on May 12 to Discuss First Quarter 2025 Financial Results and Recent Operational Highlights

PR Newswire
·
01 May

Bank of America Securities Reaffirms Their Buy Rating on RegenXBio (RGNX)

TIPRANKS
·
30 Apr